Post

MSF Access@msfaccess.org

In a commentary published in The Lancet today, MSF calls for urgent action to ensure children are included in Bundibugyo research on treatment and prevention and have timely access to paediatric formulations for oral post-exposure prophylaxis trials. www.thelancet.com/journals/lan...

thelancet.comAn urgent opportunity to ensure children's access to oral post-exposure prophylaxis trials for Bundibugyo virus diseaseChildren and pregnant women are known to be at high risk of death from Ebola virus disease.1,2 In the current outbreak of Bundibugyo virus in the Democratic Republic of the Congo, the inequality in ou...